IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Milano.

AIR nasce in UNIMI nel 2006 con lo scopo di raccogliere, documentare e conservare le informazioni sulla produzione scientifica dell'Università degli Studi di Milano e costituisce di fatto l'Anagrafe della ricerca dell'Ateneo.

LICITRA, LISA FRANCESCA LINDA

Rete di Collaborazioni Statistiche Email Alert RSS Feed

Pubblicazioni

Risultati 1 - 20 di 285 (tempo di esecuzione: 0.001 secondi).

	Titolo	Data di pubblicazione	Autori	Tipo	File	Abstract
1	Absence of ALK and MET alterations in head and neck sarcomatoid carcinoma	2016	PERRONE, FRANCESCA PIA ; P. Bossi; B. Cortelazzi; G. P. Dagrada; N. Paielli; LICITRA, LISA FRANCESCA LINDA ; S. Pilotti	Article (author)	riservati	-
2	Activation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide	13-ago-2018	Merlano, Marco C; Merlotti, Anna M; LICITRA, LISA FRANCESCA LINDA ; Denaro, Nerina; Fea, Elena; Galizia, Danilo; Di Maio, Massimo; Fruttero, Claudia; Curcio, Paola; Vecchio, Stefania; Russi, Elvio G; Corvò, Renzo	Article (author)	riservati
3	Activity and safety of afatinib in a window pre-operative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)	2018	Machiels, J P; Bossi, P; Menis, J; Lia, M; Fortpied, C; LIU, YINLU ; Lhommel, R; Lemort, M; Schmitz, S; Canevari, S; De Cecco, L; Guzzo, M; Bianchi, R; Quattrone, P; Crippa, F; Duprez, T; Lalami, Y; Quiriny, M; de Saint Aubain, N; Clement, P M; Coropciuc, R; Hauben, E; LICITRA, LISA FRANCESCA LINDA	Article (author)	riservati
4	Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy	2014	L. D. Locati; F. Perrone; B. Cortelazzi; M. Imbimbo; P. Bossi; P. Potepan; E. Civelli; G. Rinaldi; P. Quattrone; LICITRA, LISA FRANCESCA LINDA ; S. Pilotti	Article (author)	riservati
5	Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment	19-dic-2019	Galbiati, Donata; Cavalieri, Stefano; Alfieri, Salvatore; Resteghini, Carlo; Bergamini, Cristiana; Orlandi, Ester; PLATINI, FRANCESCA ; Locati, Laura; Giacomelli, Luca; LICITRA, LISA FRANCESCA LINDA ; BOSSI, PAOLO	Article (author)	Open Access
6	Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors : literature review and consensus	2015	E. G. Russi; F. Moretto; M. Rampino; M. Benasso; A. Bacigalupo; V. De Sanctis; G. Numico; P. Bossi; M. Buglione; A. Lombardo; M. Airoldi; M. C. Merlano; LICITRA, LISA FRANCESCA LINDA ; N. Denaro; S. Pergolizzi; C. Pinto; R. J. Bensadoun; G. Girolomoni; J. A. Langendijk	Article (author)	riservati
7	Adding docetaxel to cisplatin and fluorouracil in patients with unresectable head and neck cancer : a cost-utility analysis	2012	N. L. Liberato; C. Rognoni; S. Rubrichi; S. Quaglini; M. Marchetti; T. Gorlia; LICITRA, LISA FRANCESCA LINDA ; J. B. Vermorken	Article (author)	riservati
8	Adenocarcinoma of ethmoid sinus : an occupational disease = Adenocarcinoma dei seni paranasali : una malattia professionale	24-ago-2004	Bimbi, G.; Saraceno, M. S.; Riccio, S.; Gatta, G.; LICITRA, LISA FRANCESCA LINDA ; Cantù, G.	Article (author)	Open Access
9	Adjuvant androgen deprivation therapy for poor-risk, androgen receptor–positive salivary duct carcinoma	mar-2019	van Boxtel, W.; Locati, L. D.; van Engen-van Grunsven, A. C. H.; Bergamini, C.; Jonker, M. A.; Fiets, E.; CAVALIERI, STEFANO ; Tooten, S.; Bos, E.; Quattrone, P.; van Herpen, C. M. L.; Verhaegh, G. W.; Schalken, J. A.; LICITRA, LISA FRANCESCA LINDA ; van Herpen C. M. L.	Article (author)	riservati
10	Advances in the changing patterns of aetiology of head and neck cancers	14-apr-2006	LICITRA, LISA FRANCESCA LINDA ; Rossini, C.; Bossi, P.; Locati, L. D.	Article (author)	riservati
11	Afatinib as second-line treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck : subgroup analyses of treatment adherence, safety and mode of afatinib administration in the LUX-Head and Neck 1 trial	ott-2019	Haddad R.; Guigay J.; Keilholz U.; Clement P. M.; Fayette J.; de Souza Viana L.; Rolland F.; Cupissol D.; Geoffrois L.; Kornek G.; LICITRA, LISA FRANCESCA LINDA ; Melichar B.; Ribaldo Nicolau U.; Rauch D.; Zanetta-Devauges S.; Cohen E. E. W.; Machiels J. P.; Tahara M.; Vermorken J.; Geng Y.; Zografos E.; Gauler T.	Article (author)	riservati
12	Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1) : an open-label, randomised phase 3 trial	2015	J. P. H. Machiels; R. I. Haddad; J. Fayette; LICITRA, LISA FRANCESCA LINDA ; M. Tahara; J. B. Vermorken; P. M. Clement; T. Gauler; D. Cupissol; J. J. Grau; J. Guigay; F. Caponigro; G. de Castro; L. de Souza Viana; U. Keilholz; J. M. del Campo; X. J. Cong; E. Ehrnrooth; E. E. W. Cohen	Article (author)	riservati
13	Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma : subgroup analysis of the LUX-Head & Neck 1 trial	1-ago-2016	P. M. Clement; T. Gauler; J. P. Machiels; R. I. Haddad; J. Fayette; LICITRA, LISA FRANCESCA LINDA ; M. Tahara; E. E. W. Cohen; D. Cupissol; J. J. Grau; J. Guigay; F. Caponigro; G. de Castro; L. de Souza Viana; U. Keilholz; J. M. del Campo; X. J. Cong; E. Ehrnrooth; J. B. Vermorken	Article (author)	riservati
14	Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes : potential therapeutic ramifications	2014	Y. Mitani; P. H. Rao; S. N. Maity; Y. Lee; R. Ferrarotto; J. C. Post; LICITRA, LISA FRANCESCA LINDA ; S. M. Lippman; M. S. Kies; R. S. Weber; C. Caulin; S. Lin; A. K. El Naggar	Article (author)	riservati
15	Antiangiogenic TKIs and advanced RAI-resistant thyroid cancer : time for rethinking treatment strategies?	2014	LICITRA, LISA FRANCESCA LINDA ; L. Locati	Article (author)	riservati	-
16	Antiemetic therapy	lug-2002	LICITRA, LISA FRANCESCA LINDA ; S. Spinazzé; F. Roila	Article (author)	riservati
17	Aprepitant versus metoclopramide, both combined with dexamethasone, for the prevention of cisplatin-induced delayed emesis : a randomized, double-blind study	2015	F. Roila; B. Ruggeri; E. Ballatori; S. Fatigoni; C. Caserta; LICITRA, LISA FRANCESCA LINDA ; MIRABILE, AURORA ; M. T. Ionta; B. Massidda; L. Cavanna; M. A. Palladino; A. Tocci; FAVA, SERGIO ; I. Colantonio; L. Angelelli; CIUFFREDA, ANNA LUCIA ; G. Fasola; F. Zerilli	Article (author)	riservati
18	Are Fusion Transcripts in Relapsed/ Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies?	12-nov-2017	Bossi, Paolo; Siano, Marco; Bergamini, Cristiana; Cossu Rocca, Maria; Sponghini, Andrea P; Giannoccaro, Marco; Tonella, Luca; Paoli, Alessandro; Marchesi, Edoardo; Perrone, Federica; Pilotti, Silvana; Locati, Laura D; Canevari, Silvana; LICITRA, LISA FRANCESCA LINDA ; De Cecco, Loris	Article (author)	Open Access
19	Assessment of quality of life using Skindex-16 in patients with advanced basal cell carcinoma treated with vismodegib in the STEVIE study	dic-2018	Hansson, Johan; Bartley, Karen; Karagiannis, Thomas; Grob, Jean-Jacques; Kunstfeld, Rainer; Dréno, Brigitte; Mortier, Laurent; Ascierto, Paolo A.; LICITRA, LISA FRANCESCA LINDA ; Dutriaux, Caroline; Thomas, Luc; Meyer, Nicolas; Guillot, Bernard; Dummer, Reinhard; Fife, Kate; Ernst, D Scott; Yim, Yeun Mi; Dimier, Natalie; Fittipaldo, Alberto; Basset-Séguin, Nicole; Hauschild, Axel	Article (author)	riservati
20	Benefits and Risks of Machine Learning Decision Support System	dic-2017	LICITRA, LISA FRANCESCA LINDA ; Trama, Annalisa; HOSNI, HYKEL	Article (author)	Open Access

Dettaglio

Nome completo

LICITRA, LISA FRANCESCA LINDA

Afferenza

Dipartimento di Oncologia ed Emato-Oncologia